

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 6.80806869 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 5.71881754 |
| 3 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.60542720 |
| 4 | angiotensin maturation (GO:0002003) | 5.27415462 |
| 5 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.02263752 |
| 6 | hemidesmosome assembly (GO:0031581) | 4.78617362 |
| 7 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.74092986 |
| 8 | cellular glucuronidation (GO:0052695) | 4.67589733 |
| 9 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.65195896 |
| 10 | uronic acid metabolic process (GO:0006063) | 4.46637000 |
| 11 | glucuronate metabolic process (GO:0019585) | 4.46637000 |
| 12 | epithelial structure maintenance (GO:0010669) | 4.45168184 |
| 13 | citrulline biosynthetic process (GO:0019240) | 4.43026635 |
| 14 | intestinal epithelial cell development (GO:0060576) | 4.38610445 |
| 15 | hepatocyte apoptotic process (GO:0097284) | 4.27379909 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 4.27034654 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 4.27034654 |
| 18 | NADH metabolic process (GO:0006734) | 4.20319517 |
| 19 | digestive system process (GO:0022600) | 4.19641822 |
| 20 | regulation of guanylate cyclase activity (GO:0031282) | 4.11491701 |
| 21 | positive regulation of pseudopodium assembly (GO:0031274) | 4.10623130 |
| 22 | transcytosis (GO:0045056) | 4.00053424 |
| 23 | multicellular organismal water homeostasis (GO:0050891) | 3.99852642 |
| 24 | vitamin A metabolic process (GO:0006776) | 3.90323013 |
| 25 | renal filtration (GO:0097205) | 3.87793223 |
| 26 | vitamin transmembrane transport (GO:0035461) | 3.78751633 |
| 27 | renal system process involved in regulation of blood volume (GO:0001977) | 3.75204019 |
| 28 | citrulline metabolic process (GO:0000052) | 3.72805654 |
| 29 | response to hepatocyte growth factor (GO:0035728) | 3.70074067 |
| 30 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.70074067 |
| 31 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.69071054 |
| 32 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.69071054 |
| 33 | primary alcohol catabolic process (GO:0034310) | 3.68197551 |
| 34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66358679 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.66358679 |
| 36 | oligosaccharide biosynthetic process (GO:0009312) | 3.66223642 |
| 37 | epoxygenase P450 pathway (GO:0019373) | 3.65874889 |
| 38 | regulation of pseudopodium assembly (GO:0031272) | 3.61726316 |
| 39 | * O-glycan processing (GO:0016266) | 3.61506954 |
| 40 | ethanol oxidation (GO:0006069) | 3.58310397 |
| 41 | ethanol metabolic process (GO:0006067) | 3.57659395 |
| 42 | bile acid and bile salt transport (GO:0015721) | 3.57416193 |
| 43 | urea cycle (GO:0000050) | 3.54952959 |
| 44 | regulation of bile acid biosynthetic process (GO:0070857) | 3.53954055 |
| 45 | glomerular filtration (GO:0003094) | 3.51582522 |
| 46 | positive regulation of respiratory burst (GO:0060267) | 3.51201046 |
| 47 | regulation of water loss via skin (GO:0033561) | 3.49471375 |
| 48 | diterpenoid biosynthetic process (GO:0016102) | 3.48467235 |
| 49 | GDP-mannose metabolic process (GO:0019673) | 3.47296869 |
| 50 | hormone catabolic process (GO:0042447) | 3.46298544 |
| 51 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.43795777 |
| 52 | actin filament depolymerization (GO:0030042) | 3.42055188 |
| 53 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.40895554 |
| 54 | endocrine process (GO:0050886) | 3.40895554 |
| 55 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.40895554 |
| 56 | adhesion of symbiont to host cell (GO:0044650) | 3.40339546 |
| 57 | virion attachment to host cell (GO:0019062) | 3.40339546 |
| 58 | regulation of cholesterol homeostasis (GO:2000188) | 3.35626042 |
| 59 | urea metabolic process (GO:0019627) | 3.34091107 |
| 60 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.32401611 |
| 61 | adhesion of symbiont to host (GO:0044406) | 3.30391377 |
| 62 | low-density lipoprotein particle clearance (GO:0034383) | 3.29130709 |
| 63 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.28166589 |
| 64 | regulation of respiratory burst (GO:0060263) | 3.27406860 |
| 65 | water homeostasis (GO:0030104) | 3.24468172 |
| 66 | positive regulation of p38MAPK cascade (GO:1900745) | 3.22738875 |
| 67 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.22572030 |
| 68 | cell adhesion mediated by integrin (GO:0033627) | 3.21340298 |
| 69 | flavonoid metabolic process (GO:0009812) | 3.16324226 |
| 70 | regulation of vitamin metabolic process (GO:0030656) | 3.13681851 |
| 71 | peptide catabolic process (GO:0043171) | 3.13329278 |
| 72 | activation of Rac GTPase activity (GO:0032863) | 3.10040990 |
| 73 | regulation of systemic arterial blood pressure (GO:0003073) | 3.08963984 |
| 74 | establishment of skin barrier (GO:0061436) | 3.08576997 |
| 75 | sodium ion homeostasis (GO:0055078) | 3.06681422 |
| 76 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.06011638 |
| 77 | glucose 6-phosphate metabolic process (GO:0051156) | 3.05061766 |
| 78 | antimicrobial humoral response (GO:0019730) | 3.03313439 |
| 79 | digestion (GO:0007586) | 3.03107437 |
| 80 | regulation of metalloenzyme activity (GO:0048552) | 3.02672882 |
| 81 | peptide hormone processing (GO:0016486) | 3.02032238 |
| 82 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.01005368 |
| 83 | antibacterial humoral response (GO:0019731) | 2.95473133 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 2.95396707 |
| 85 | gap junction assembly (GO:0016264) | 2.95039002 |
| 86 | establishment of endothelial barrier (GO:0061028) | 2.94365692 |
| 87 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.93291955 |
| 88 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.92331961 |
| 89 | endocrine pancreas development (GO:0031018) | 2.91274261 |
| 90 | lipoprotein metabolic process (GO:0042157) | 2.90935118 |
| 91 | mesodermal cell differentiation (GO:0048333) | 2.90833046 |
| 92 | sphingomyelin metabolic process (GO:0006684) | 2.89272223 |
| 93 | drug metabolic process (GO:0017144) | 2.88864612 |
| 94 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.88139715 |
| 95 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.87889178 |
| 96 | COPII vesicle coating (GO:0048208) | 2.87682982 |
| 97 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.87557157 |
| 98 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.86653912 |
| 99 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.85992223 |
| 100 | hypotonic response (GO:0006971) | 2.84803340 |
| 101 | sulfation (GO:0051923) | 2.84756870 |
| 102 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.83351419 |
| 103 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.82859600 |
| 104 | regulation of cholesterol storage (GO:0010885) | 2.82729808 |
| 105 | decidualization (GO:0046697) | 2.81551339 |
| 106 | auditory receptor cell differentiation (GO:0042491) | 2.81254769 |
| 107 | proline biosynthetic process (GO:0006561) | 2.78156507 |
| 108 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.77753049 |
| 109 | protein retention in ER lumen (GO:0006621) | 2.77209892 |
| 110 | excretion (GO:0007588) | 2.74353219 |
| 111 | glutathione biosynthetic process (GO:0006750) | 2.73656471 |
| 112 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.72566407 |
| 113 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.72432611 |
| 114 | protein autoprocessing (GO:0016540) | 2.71262503 |
| 115 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.70239066 |
| 116 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.69419133 |
| 117 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68824938 |
| 118 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.67880896 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.67880896 |
| 120 | lipoprotein transport (GO:0042953) | 2.65765570 |
| 121 | protein-lipid complex assembly (GO:0065005) | 2.65520221 |
| 122 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.64625076 |
| 123 | plasma lipoprotein particle assembly (GO:0034377) | 2.61927474 |
| 124 | primary alcohol metabolic process (GO:0034308) | 2.61593075 |
| 125 | phospholipid scrambling (GO:0017121) | 2.60864385 |
| 126 | cyclooxygenase pathway (GO:0019371) | 2.60838422 |
| 127 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.60733960 |
| 128 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.60492715 |
| 129 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.59476655 |
| 130 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.58772556 |
| 131 | amyloid precursor protein metabolic process (GO:0042982) | 2.58534118 |
| 132 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.57565015 |
| 133 | desmosome organization (GO:0002934) | 2.57293076 |
| 134 | apoptotic cell clearance (GO:0043277) | 2.57201653 |
| 135 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.55236581 |
| 136 | drug catabolic process (GO:0042737) | 2.53585781 |
| 137 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51975800 |
| 138 | regulation of viral release from host cell (GO:1902186) | 2.51466910 |
| 139 | skin morphogenesis (GO:0043589) | 2.50745301 |
| 140 | glandular epithelial cell differentiation (GO:0002067) | 2.49095223 |
| 141 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.48373860 |
| 142 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.47729024 |
| 143 | thrombin receptor signaling pathway (GO:0070493) | 2.47392363 |
| 144 | regulation of integrin activation (GO:0033623) | 2.46403403 |
| 145 | protein kinase C signaling (GO:0070528) | 2.45321203 |
| 146 | regulation of cellular extravasation (GO:0002691) | 2.44261038 |
| 147 | sequestering of metal ion (GO:0051238) | 2.43382814 |
| 148 | diol metabolic process (GO:0034311) | 2.42966701 |
| 149 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.42894175 |
| 150 | phospholipid efflux (GO:0033700) | 2.42688763 |
| 151 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.42457885 |
| 152 | tight junction assembly (GO:0070830) | 2.41685324 |
| 153 | epithelial cell-cell adhesion (GO:0090136) | 2.40310545 |
| 154 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.39880232 |
| 155 | sulfate transmembrane transport (GO:1902358) | 2.39554150 |
| 156 | regulation of chemokine secretion (GO:0090196) | 2.37888968 |
| 157 | morphogenesis of an endothelium (GO:0003159) | 2.37787167 |
| 158 | endothelial tube morphogenesis (GO:0061154) | 2.37787167 |
| 159 | substrate-dependent cell migration (GO:0006929) | 2.37381473 |
| 160 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.36247798 |
| 161 | leukocyte tethering or rolling (GO:0050901) | 2.35703379 |
| 162 | regulation of podosome assembly (GO:0071801) | 2.35356298 |
| 163 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.34793130 |
| 164 | regulation of p38MAPK cascade (GO:1900744) | 2.34624802 |
| 165 | protein localization to endosome (GO:0036010) | 2.32697802 |
| 166 | sterol homeostasis (GO:0055092) | 2.30346399 |
| 167 | sterol transport (GO:0015918) | 2.29279916 |
| 168 | cholesterol transport (GO:0030301) | 2.29279916 |
| 169 | cholesterol homeostasis (GO:0042632) | 2.27957426 |
| 170 | nitric oxide biosynthetic process (GO:0006809) | 2.27757720 |
| 171 | thyroid hormone metabolic process (GO:0042403) | 2.27407320 |
| 172 | trophectodermal cell differentiation (GO:0001829) | 2.27239334 |
| 173 | interferon-gamma secretion (GO:0072643) | 2.27234833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.15575484 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.34069012 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.22082519 |
| 4 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.11013108 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.96373769 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69995400 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.55079263 |
| 8 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.50294213 |
| 9 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.40352857 |
| 10 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.36734253 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.33584663 |
| 12 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.28971845 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.22336897 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21567628 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.15064484 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14298665 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.14128242 |
| 18 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.10762869 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.08811894 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08081172 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.06541647 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.01930028 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.95981437 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.95579153 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94654257 |
| 26 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.91358620 |
| 27 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.90170665 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.87503535 |
| 29 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.86912769 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86203642 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83668798 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.81981701 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77781813 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76703639 |
| 35 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.69622720 |
| 36 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.66982729 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58330608 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57865268 |
| 39 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.56376098 |
| 40 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.53057195 |
| 41 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.53057195 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.52750131 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52411223 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51627057 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51542081 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50688515 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50643164 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48699426 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48474643 |
| 50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47280891 |
| 51 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46125620 |
| 52 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.44114028 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.36806414 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36381791 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35198646 |
| 56 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35010222 |
| 57 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35007744 |
| 58 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.33766478 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33597913 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33341416 |
| 61 | GATA2_19941826_ChIP-Seq_K562_Human | 1.29105362 |
| 62 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.26923940 |
| 63 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25236780 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24291794 |
| 65 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.24122341 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23531521 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22873894 |
| 68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22867347 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21484207 |
| 70 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.20225576 |
| 71 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20169280 |
| 72 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.18257010 |
| 73 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17686911 |
| 74 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16963246 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.15915526 |
| 76 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15816195 |
| 77 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.14999082 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14516771 |
| 79 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11271347 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09272059 |
| 81 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09183597 |
| 82 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08707682 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07547264 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06772557 |
| 85 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05690189 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05336389 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05092034 |
| 88 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.04652766 |
| 89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04312646 |
| 90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02005121 |
| 91 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01940180 |
| 92 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01220469 |
| 93 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00956170 |
| 94 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00604738 |
| 95 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00601821 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00191140 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99569810 |
| 98 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98695420 |
| 99 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98544575 |
| 100 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98528052 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96814738 |
| 102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96227113 |
| 103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96158419 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95639994 |
| 105 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95152054 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94511986 |
| 107 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94180942 |
| 108 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93986399 |
| 109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93431719 |
| 110 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92400374 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92357339 |
| 112 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92169291 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.91786849 |
| 114 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91264948 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.90832884 |
| 116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90137902 |
| 117 | * MAF_26560356_Chip-Seq_TH1_Human | 0.90114450 |
| 118 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.89913329 |
| 119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89868044 |
| 120 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89573717 |
| 121 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.89171468 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88969170 |
| 123 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87738672 |
| 124 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86084444 |
| 125 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.83867881 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83721546 |
| 127 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83412746 |
| 128 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82242697 |
| 129 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.81371567 |
| 130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81252503 |
| 131 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80491460 |
| 132 | * P68_20966046_ChIP-Seq_HELA_Human | 0.78929300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.48347900 |
| 2 | MP0005360_urolithiasis | 3.71822710 |
| 3 | MP0008004_abnormal_stomach_pH | 3.67385267 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.63838512 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.29801007 |
| 6 | MP0006054_spinal_hemorrhage | 3.16682910 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.13013496 |
| 8 | MP0000566_synostosis | 2.84154876 |
| 9 | MP0003866_abnormal_defecation | 2.68259966 |
| 10 | MP0001873_stomach_inflammation | 2.51696964 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.36871167 |
| 12 | MP0000462_abnormal_digestive_system | 2.31040245 |
| 13 | MP0009840_abnormal_foam_cell | 2.29026603 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.22023257 |
| 15 | MP0010155_abnormal_intestine_physiology | 2.20231564 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.16491975 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.14212501 |
| 18 | MP0000537_abnormal_urethra_morphology | 2.05462733 |
| 19 | MP0009379_abnormal_foot_pigmentation | 2.05270946 |
| 20 | MP0003724_increased_susceptibility_to | 2.01260016 |
| 21 | MP0005409_darkened_coat_color | 1.95951823 |
| 22 | MP0001663_abnormal_digestive_system | 1.82546183 |
| 23 | MP0005083_abnormal_biliary_tract | 1.77579868 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.76324417 |
| 25 | MP0003252_abnormal_bile_duct | 1.72746442 |
| 26 | MP0001879_abnormal_lymphatic_vessel | 1.72531502 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.70357095 |
| 28 | MP0004947_skin_inflammation | 1.70205547 |
| 29 | MP0005381_digestive/alimentary_phenotyp | 1.69132689 |
| 30 | MP0000678_abnormal_parathyroid_gland | 1.65838986 |
| 31 | MP0000490_abnormal_crypts_of | 1.64802168 |
| 32 | MP0005451_abnormal_body_composition | 1.64614712 |
| 33 | MP0001664_abnormal_digestion | 1.62636562 |
| 34 | MP0000477_abnormal_intestine_morphology | 1.62202629 |
| 35 | MP0001849_ear_inflammation | 1.61136510 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.57751750 |
| 37 | MP0000467_abnormal_esophagus_morphology | 1.55537212 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.53237713 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.51455059 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.47843744 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41623056 |
| 42 | MP0003303_peritoneal_inflammation | 1.39855068 |
| 43 | MP0005310_abnormal_salivary_gland | 1.35293620 |
| 44 | MP0002139_abnormal_hepatobiliary_system | 1.34825340 |
| 45 | MP0004272_abnormal_basement_membrane | 1.31185898 |
| 46 | MP0005670_abnormal_white_adipose | 1.28384967 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.28270796 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.28267394 |
| 49 | MP0003868_abnormal_feces_composition | 1.26371265 |
| 50 | MP0010678_abnormal_skin_adnexa | 1.20418097 |
| 51 | MP0002796_impaired_skin_barrier | 1.19365964 |
| 52 | MP0003436_decreased_susceptibility_to | 1.19214070 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.16482964 |
| 54 | MP0000383_abnormal_hair_follicle | 1.13774895 |
| 55 | MP0000762_abnormal_tongue_morphology | 1.09460984 |
| 56 | MP0004858_abnormal_nervous_system | 1.09431063 |
| 57 | MP0000609_abnormal_liver_physiology | 1.08260556 |
| 58 | MP0004043_abnormal_pH_regulation | 1.07552470 |
| 59 | MP0003283_abnormal_digestive_organ | 1.06564472 |
| 60 | MP0000538_abnormal_urinary_bladder | 1.05860083 |
| 61 | MP0000470_abnormal_stomach_morphology | 1.05598883 |
| 62 | MP0004147_increased_porphyrin_level | 1.04612856 |
| 63 | MP0010771_integument_phenotype | 1.04376827 |
| 64 | MP0000377_abnormal_hair_follicle | 1.03191477 |
| 65 | MP0005023_abnormal_wound_healing | 1.02953588 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.02177118 |
| 67 | MP0000013_abnormal_adipose_tissue | 1.01293626 |
| 68 | MP0009785_altered_susceptibility_to | 1.00692070 |
| 69 | MP0005275_abnormal_skin_tensile | 1.00430615 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.00119997 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 0.99725786 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.99557000 |
| 73 | MP0001756_abnormal_urination | 0.97263451 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 0.96751650 |
| 75 | MP0005076_abnormal_cell_differentiation | 0.96710762 |
| 76 | MP0001845_abnormal_inflammatory_respons | 0.96657038 |
| 77 | MP0000579_abnormal_nail_morphology | 0.96507647 |
| 78 | MP0005365_abnormal_bile_salt | 0.96245207 |
| 79 | MP0005332_abnormal_amino_acid | 0.95955722 |
| 80 | MP0005025_abnormal_response_to | 0.95800420 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.95287253 |
| 82 | MP0001765_abnormal_ion_homeostasis | 0.94757789 |
| 83 | MP0001216_abnormal_epidermal_layer | 0.94727584 |
| 84 | MP0002876_abnormal_thyroid_physiology | 0.94473834 |
| 85 | MP0000627_abnormal_mammary_gland | 0.93636574 |
| 86 | MP0005501_abnormal_skin_physiology | 0.91870533 |
| 87 | MP0003045_fibrosis | 0.91436833 |
| 88 | MP0005464_abnormal_platelet_physiology | 0.90905739 |
| 89 | MP0002098_abnormal_vibrissa_morphology | 0.90608887 |
| 90 | MP0005165_increased_susceptibility_to | 0.89978613 |
| 91 | MP0005166_decreased_susceptibility_to | 0.89960094 |
| 92 | MP0002254_reproductive_system_inflammat | 0.89715304 |
| 93 | MP0001881_abnormal_mammary_gland | 0.88425243 |
| 94 | MP0002909_abnormal_adrenal_gland | 0.87589956 |
| 95 | MP0003941_abnormal_skin_development | 0.85499475 |
| 96 | MP0000249_abnormal_blood_vessel | 0.85096291 |
| 97 | MP0004185_abnormal_adipocyte_glucose | 0.85070215 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.84698224 |
| 99 | MP0002060_abnormal_skin_morphology | 0.84489503 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.83621910 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.83313492 |
| 102 | MP0002148_abnormal_hypersensitivity_rea | 0.80928560 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.80772707 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.80511820 |
| 105 | MP0001191_abnormal_skin_condition | 0.79688311 |
| 106 | MP0005257_abnormal_intraocular_pressure | 0.77975577 |
| 107 | MP0002419_abnormal_innate_immunity | 0.77910234 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.77699743 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.76383722 |
| 110 | MP0003828_pulmonary_edema | 0.75890794 |
| 111 | MP0003091_abnormal_cell_migration | 0.75020113 |
| 112 | MP0009931_abnormal_skin_appearance | 0.74558298 |
| 113 | MP0003315_abnormal_perineum_morphology | 0.73555763 |
| 114 | MP0008469_abnormal_protein_level | 0.72402835 |
| 115 | MP0005375_adipose_tissue_phenotype | 0.72172072 |
| 116 | MP0009333_abnormal_splenocyte_physiolog | 0.71281468 |
| 117 | MP0000604_amyloidosis | 0.70892213 |
| 118 | MP0003075_altered_response_to | 0.70013577 |
| 119 | MP0000858_altered_metastatic_potential | 0.69740395 |
| 120 | MP0001790_abnormal_immune_system | 0.69145841 |
| 121 | MP0005387_immune_system_phenotype | 0.69145841 |
| 122 | MP0009780_abnormal_chondrocyte_physiolo | 0.68720023 |
| 123 | MP0002006_tumorigenesis | 0.68368697 |
| 124 | MP0010307_abnormal_tumor_latency | 0.67747516 |
| 125 | MP0003879_abnormal_hair_cell | 0.67178111 |
| 126 | MP0002118_abnormal_lipid_homeostasis | 0.67149664 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.66718588 |
| 128 | MP0002089_abnormal_postnatal_growth/wei | 0.61208910 |
| 129 | MP0001764_abnormal_homeostasis | 0.55019254 |
| 130 | MP0003329_amyloid_beta_deposits | 0.51396058 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51084363 |
| 132 | MP0000367_abnormal_coat/_hair | 0.50547436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 5.20015049 |
| 2 | Ileus (HP:0002595) | 5.06223204 |
| 3 | Decreased circulating renin level (HP:0003351) | 4.20218638 |
| 4 | Abnormality of renin-angiotensin system (HP:0000847) | 4.02634923 |
| 5 | Pustule (HP:0200039) | 3.84285021 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 3.67397733 |
| 7 | Abdominal distention (HP:0003270) | 3.60067511 |
| 8 | Milia (HP:0001056) | 3.58283321 |
| 9 | Onycholysis (HP:0001806) | 3.46300460 |
| 10 | Malnutrition (HP:0004395) | 3.43724628 |
| 11 | Chronic bronchitis (HP:0004469) | 3.35069128 |
| 12 | Nonimmune hydrops fetalis (HP:0001790) | 3.33398349 |
| 13 | Abnormal hair laboratory examination (HP:0003328) | 3.24193934 |
| 14 | Polycythemia (HP:0001901) | 3.23542603 |
| 15 | Esophageal varix (HP:0002040) | 3.20952375 |
| 16 | Hyperaldosteronism (HP:0000859) | 3.18931514 |
| 17 | Flat acetabular roof (HP:0003180) | 3.07347301 |
| 18 | Atrophic scars (HP:0001075) | 3.06615558 |
| 19 | Alkalosis (HP:0001948) | 3.05366620 |
| 20 | Metabolic alkalosis (HP:0200114) | 3.03076864 |
| 21 | Micronodular cirrhosis (HP:0001413) | 3.02436363 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.97903654 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 2.93042009 |
| 24 | Hyperactive renin-angiotensin system (HP:0000841) | 2.90209268 |
| 25 | Mucopolysacchariduria (HP:0008155) | 2.89644791 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.89644791 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 2.85235321 |
| 28 | Abnormality of proline metabolism (HP:0010907) | 2.83056036 |
| 29 | Hydroxyprolinuria (HP:0003080) | 2.83056036 |
| 30 | Fragile nails (HP:0001808) | 2.74766450 |
| 31 | Hyponatremia (HP:0002902) | 2.71184845 |
| 32 | Acanthocytosis (HP:0001927) | 2.66145272 |
| 33 | Abnormality of the gastric mucosa (HP:0004295) | 2.65948907 |
| 34 | Hyperkalemia (HP:0002153) | 2.64616136 |
| 35 | Hypoglycemic coma (HP:0001325) | 2.61632334 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61405998 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61405998 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61405998 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 2.57824230 |
| 40 | Rectal prolapse (HP:0002035) | 2.54195226 |
| 41 | Alopecia of scalp (HP:0002293) | 2.52819843 |
| 42 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.52095050 |
| 43 | Symptomatic seizures (HP:0011145) | 2.51050004 |
| 44 | Abnormality of carpal bone ossification (HP:0006257) | 2.48098002 |
| 45 | Gout (HP:0001997) | 2.47275747 |
| 46 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.46604274 |
| 47 | Hypotension (HP:0002615) | 2.46140645 |
| 48 | Focal segmental glomerulosclerosis (HP:0000097) | 2.45721419 |
| 49 | Hematochezia (HP:0002573) | 2.42528457 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.40530196 |
| 51 | Widely patent fontanelles and sutures (HP:0004492) | 2.39901504 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.38409495 |
| 53 | Nasal polyposis (HP:0100582) | 2.36890886 |
| 54 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.34918266 |
| 55 | Villous atrophy (HP:0011473) | 2.34918266 |
| 56 | Spinal cord compression (HP:0002176) | 2.32318806 |
| 57 | Plantar hyperkeratosis (HP:0007556) | 2.30559192 |
| 58 | Gastrointestinal dysmotility (HP:0002579) | 2.30400051 |
| 59 | Hypobetalipoproteinemia (HP:0003563) | 2.30041952 |
| 60 | Distal lower limb amyotrophy (HP:0008944) | 2.29960381 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.29491711 |
| 62 | Chronic diarrhea (HP:0002028) | 2.29277885 |
| 63 | Abnormality of chloride homeostasis (HP:0011422) | 2.27907335 |
| 64 | Cupped ribs (HP:0000887) | 2.27335728 |
| 65 | Renal salt wasting (HP:0000127) | 2.22916093 |
| 66 | Abnormal biliary tract morphology (HP:0012440) | 2.21602355 |
| 67 | Late onset (HP:0003584) | 2.21471325 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.20578286 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.20000042 |
| 70 | Hyperparathyroidism (HP:0000843) | 2.17243023 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.16567569 |
| 72 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.15608001 |
| 73 | Growth hormone excess (HP:0000845) | 2.14609973 |
| 74 | Fatigue (HP:0012378) | 2.14336517 |
| 75 | Hyperuricemia (HP:0002149) | 2.12729075 |
| 76 | Increased purine levels (HP:0004368) | 2.12729075 |
| 77 | Ventricular tachycardia (HP:0004756) | 2.11789586 |
| 78 | Vascular calcification (HP:0004934) | 2.11246079 |
| 79 | Abnormality of purine metabolism (HP:0004352) | 2.11007320 |
| 80 | Woolly hair (HP:0002224) | 2.10830510 |
| 81 | Fat malabsorption (HP:0002630) | 2.10759783 |
| 82 | Dehydration (HP:0001944) | 2.08882594 |
| 83 | Distal upper limb amyotrophy (HP:0007149) | 2.08580228 |
| 84 | Upper limb amyotrophy (HP:0009129) | 2.08580228 |
| 85 | Abnormal ossification of hand bones (HP:0005921) | 2.08300156 |
| 86 | Abnormality of complement system (HP:0005339) | 2.07106711 |
| 87 | Increased cerebral lipofuscin (HP:0011813) | 2.04885660 |
| 88 | Curly hair (HP:0002212) | 2.04306224 |
| 89 | Abnormal hand bone ossification (HP:0010660) | 2.03363958 |
| 90 | Axonal loss (HP:0003447) | 2.03291790 |
| 91 | Flattened epiphyses (HP:0003071) | 2.03193364 |
| 92 | Subcapsular cataract (HP:0000523) | 2.02762481 |
| 93 | Pili torti (HP:0003777) | 2.01971898 |
| 94 | Pterygium (HP:0001059) | 2.01732442 |
| 95 | Abnormal blistering of the skin (HP:0008066) | 2.01346803 |
| 96 | Subacute progressive viral hepatitis (HP:0006572) | 2.00872536 |
| 97 | Fragile skin (HP:0001030) | 2.00811918 |
| 98 | Hyperglycemia (HP:0003074) | 2.00809484 |
| 99 | Abnormality of vitamin metabolism (HP:0100508) | 2.00272031 |
| 100 | Increased mean platelet volume (HP:0011877) | 2.00234147 |
| 101 | Cervical subluxation (HP:0003308) | 2.00097115 |
| 102 | Thin bony cortex (HP:0002753) | 1.99728430 |
| 103 | Deep venous thrombosis (HP:0002625) | 1.99591444 |
| 104 | Hypoplasia of dental enamel (HP:0006297) | 1.98354781 |
| 105 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.97905564 |
| 106 | Severe short stature (HP:0003510) | 1.96432345 |
| 107 | Adrenal overactivity (HP:0002717) | 1.94867871 |
| 108 | Cheilitis (HP:0100825) | 1.94209090 |
| 109 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93751817 |
| 110 | Broad face (HP:0000283) | 1.92451425 |
| 111 | Ureteral stenosis (HP:0000071) | 1.91569665 |
| 112 | Abnormal platelet function (HP:0011869) | 1.91304792 |
| 113 | Impaired platelet aggregation (HP:0003540) | 1.91304792 |
| 114 | Progressive hearing impairment (HP:0001730) | 1.90238898 |
| 115 | Abnormality of sodium homeostasis (HP:0010931) | 1.90094294 |
| 116 | Spontaneous hematomas (HP:0007420) | 1.90063495 |
| 117 | Nephritis (HP:0000123) | 1.89767375 |
| 118 | Complement deficiency (HP:0004431) | 1.89147586 |
| 119 | Cardiovascular calcification (HP:0011915) | 1.89112701 |
| 120 | Abnormal vertebral ossification (HP:0100569) | 1.88825545 |
| 121 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.88138042 |
| 122 | Hyperphosphatemia (HP:0002905) | 1.87238571 |
| 123 | Ureteral obstruction (HP:0006000) | 1.86666740 |
| 124 | Mesangial abnormality (HP:0001966) | 1.86107203 |
| 125 | Eczematoid dermatitis (HP:0000976) | 1.86075620 |
| 126 | Poikilocytosis (HP:0004447) | 1.85649118 |
| 127 | Insulin resistance (HP:0000855) | 1.85613735 |
| 128 | Hyperammonemia (HP:0001987) | 1.85203447 |
| 129 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.84899605 |
| 130 | Steatorrhea (HP:0002570) | 1.84641925 |
| 131 | Palmoplantar hyperkeratosis (HP:0000972) | 1.83959173 |
| 132 | Wide cranial sutures (HP:0010537) | 1.83689513 |
| 133 | Increased IgE level (HP:0003212) | 1.83071639 |
| 134 | Glomerulosclerosis (HP:0000096) | 1.82673360 |
| 135 | Hemorrhage of the eye (HP:0011885) | 1.82494253 |
| 136 | Bone pain (HP:0002653) | 1.82412142 |
| 137 | Palpitations (HP:0001962) | 1.82342130 |
| 138 | Abnormal platelet volume (HP:0011876) | 1.81905577 |
| 139 | Biliary tract neoplasm (HP:0100574) | 1.81318282 |
| 140 | Abnormality of potassium homeostasis (HP:0011042) | 1.80973602 |
| 141 | Intrahepatic cholestasis (HP:0001406) | 1.80801883 |
| 142 | Glomerulonephritis (HP:0000099) | 1.80561005 |
| 143 | Hypolipoproteinemia (HP:0010981) | 1.79913623 |
| 144 | Abnormality of macrophages (HP:0004311) | 1.79481675 |
| 145 | Progressive sensorineural hearing impairment (HP:0000408) | 1.79414338 |
| 146 | Short nail (HP:0001799) | 1.78806960 |
| 147 | Xanthomatosis (HP:0000991) | 1.78568796 |
| 148 | Popliteal pterygium (HP:0009756) | 1.77491748 |
| 149 | Congenital sensorineural hearing impairment (HP:0008527) | 1.76333874 |
| 150 | Abnormal tarsal ossification (HP:0008369) | 1.76218255 |
| 151 | Abnormal albumin level (HP:0012116) | 1.74262313 |
| 152 | Hypoalbuminemia (HP:0003073) | 1.74262313 |
| 153 | Pigmentary retinal degeneration (HP:0001146) | 1.74050796 |
| 154 | Reticulocytosis (HP:0001923) | 1.74047645 |
| 155 | Aneurysm (HP:0002617) | 1.73872341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.39025188 |
| 2 | MST4 | 3.79047626 |
| 3 | KDR | 3.72983936 |
| 4 | FRK | 3.52338808 |
| 5 | ERN1 | 3.35780183 |
| 6 | MST1R | 3.29881658 |
| 7 | TIE1 | 2.59861008 |
| 8 | PTK6 | 2.56175502 |
| 9 | RIPK1 | 2.54477428 |
| 10 | PRKG2 | 2.46274416 |
| 11 | LMTK2 | 2.38567632 |
| 12 | MAP2K2 | 2.13592123 |
| 13 | TRIB3 | 1.92566808 |
| 14 | PKN2 | 1.91736415 |
| 15 | STK10 | 1.84331372 |
| 16 | PTK2 | 1.81052851 |
| 17 | ACVR1B | 1.76011333 |
| 18 | MAP3K2 | 1.70356241 |
| 19 | TGFBR2 | 1.62174424 |
| 20 | MET | 1.59675283 |
| 21 | EPHB1 | 1.56936096 |
| 22 | TESK1 | 1.56179812 |
| 23 | SMG1 | 1.52184175 |
| 24 | PAK4 | 1.47308510 |
| 25 | MAP3K12 | 1.45573799 |
| 26 | NME1 | 1.44125900 |
| 27 | MAP3K3 | 1.41616118 |
| 28 | TBK1 | 1.40919188 |
| 29 | NME2 | 1.40423168 |
| 30 | STK39 | 1.38697156 |
| 31 | FER | 1.34887496 |
| 32 | STK24 | 1.34669610 |
| 33 | MAP3K10 | 1.34604203 |
| 34 | EPHB2 | 1.31652621 |
| 35 | GRK6 | 1.27871478 |
| 36 | ERBB4 | 1.27847507 |
| 37 | TAOK3 | 1.24762135 |
| 38 | LRRK2 | 1.24179683 |
| 39 | FGFR4 | 1.16947020 |
| 40 | JAK3 | 1.07268058 |
| 41 | CSK | 1.05266292 |
| 42 | ICK | 1.02401917 |
| 43 | TYK2 | 1.02387525 |
| 44 | SCYL2 | 0.99935065 |
| 45 | TGFBR1 | 0.97739838 |
| 46 | MAP2K1 | 0.97208934 |
| 47 | TESK2 | 0.92975396 |
| 48 | BMX | 0.89440710 |
| 49 | MAP4K1 | 0.89281075 |
| 50 | ZAP70 | 0.89269327 |
| 51 | FLT3 | 0.88265014 |
| 52 | PBK | 0.87861238 |
| 53 | MAP3K14 | 0.85374739 |
| 54 | PIM2 | 0.85326791 |
| 55 | INSRR | 0.83095952 |
| 56 | JAK1 | 0.82120436 |
| 57 | MAP3K1 | 0.81707466 |
| 58 | MYLK | 0.75306138 |
| 59 | DMPK | 0.74066707 |
| 60 | PDGFRA | 0.73647104 |
| 61 | EEF2K | 0.73557207 |
| 62 | NUAK1 | 0.73482237 |
| 63 | MAPK15 | 0.73353337 |
| 64 | MAP3K11 | 0.72750822 |
| 65 | MATK | 0.72697807 |
| 66 | LATS1 | 0.72112419 |
| 67 | MAP3K8 | 0.71163251 |
| 68 | PRKCI | 0.70065397 |
| 69 | TTN | 0.68895145 |
| 70 | TAOK1 | 0.67339762 |
| 71 | RIPK4 | 0.66803592 |
| 72 | JAK2 | 0.65813034 |
| 73 | CDK6 | 0.64273273 |
| 74 | MAPKAPK3 | 0.62605806 |
| 75 | PASK | 0.61806827 |
| 76 | AKT3 | 0.60321744 |
| 77 | CHUK | 0.60048600 |
| 78 | KSR2 | 0.59820804 |
| 79 | CDC42BPA | 0.59094582 |
| 80 | IKBKE | 0.57896911 |
| 81 | IRAK3 | 0.56567092 |
| 82 | MAP2K3 | 0.52424007 |
| 83 | DYRK1B | 0.50889132 |
| 84 | OXSR1 | 0.50635322 |
| 85 | FGFR3 | 0.49317430 |
| 86 | STK3 | 0.49264464 |
| 87 | EGFR | 0.47509656 |
| 88 | RPS6KA4 | 0.47355045 |
| 89 | PIK3CA | 0.46850484 |
| 90 | ERBB2 | 0.46654996 |
| 91 | TRPM7 | 0.45527401 |
| 92 | ITK | 0.43816115 |
| 93 | PRKAA2 | 0.43124413 |
| 94 | BLK | 0.41805476 |
| 95 | WNK4 | 0.41551952 |
| 96 | GSK3A | 0.41124290 |
| 97 | EPHA3 | 0.40599148 |
| 98 | PDGFRB | 0.40111741 |
| 99 | MAPKAPK2 | 0.39168485 |
| 100 | CDK12 | 0.38927463 |
| 101 | SRC | 0.38337149 |
| 102 | DDR2 | 0.37485598 |
| 103 | MAP2K6 | 0.37304920 |
| 104 | MAPK11 | 0.37102024 |
| 105 | STK38 | 0.35792724 |
| 106 | CDK9 | 0.35301920 |
| 107 | CAMK2G | 0.35301580 |
| 108 | CAMK2D | 0.34971172 |
| 109 | NEK6 | 0.34090084 |
| 110 | HIPK2 | 0.32699004 |
| 111 | PAK3 | 0.32618740 |
| 112 | ABL2 | 0.32333984 |
| 113 | PAK2 | 0.31911394 |
| 114 | NTRK1 | 0.30695200 |
| 115 | PRPF4B | 0.29641199 |
| 116 | GRK1 | 0.28989286 |
| 117 | PDPK1 | 0.28905827 |
| 118 | CDK8 | 0.28856497 |
| 119 | MAP3K9 | 0.28671822 |
| 120 | NEK1 | 0.28334365 |
| 121 | SIK1 | 0.28301613 |
| 122 | RPS6KB2 | 0.28033252 |
| 123 | ARAF | 0.27750004 |
| 124 | RET | 0.26158436 |
| 125 | ILK | 0.26022068 |
| 126 | IGF1R | 0.25740008 |
| 127 | MELK | 0.24849321 |
| 128 | RPS6KA2 | 0.24658065 |
| 129 | SIK3 | 0.24127798 |
| 130 | DAPK1 | 0.24001246 |
| 131 | EIF2AK1 | 0.23165285 |
| 132 | IRAK1 | 0.22219381 |
| 133 | MAP3K6 | 0.19539372 |
| 134 | MTOR | 0.19512029 |
| 135 | PRKD2 | 0.18444671 |
| 136 | PRKCD | 0.17415263 |
| 137 | BCR | 0.16085376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.30307085 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.72378597 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.68304393 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.26993389 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 3.22755913 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.16236951 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.64259172 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.53935417 |
| 9 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.47514700 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.29122669 |
| 11 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.25977253 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.14636047 |
| 13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.09500723 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 2.06408017 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.99466903 |
| 16 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.91812589 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.87320925 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63276907 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.60493141 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56381041 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.53280800 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49592983 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.44229432 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40644304 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.33486219 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.30565526 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.29030885 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28222180 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25625849 |
| 30 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.25527232 |
| 31 | Adherens junction_Homo sapiens_hsa04520 | 1.24794474 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23980621 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15721970 |
| 34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10716252 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.09235073 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.03402546 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03167085 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02685941 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02327707 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.02243796 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01793135 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00907071 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00296756 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99023979 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 0.98875885 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96594979 |
| 47 | Tight junction_Homo sapiens_hsa04530 | 0.96552293 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95970574 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.94561390 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.94549932 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.93096751 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92859783 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92524788 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92290736 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91890841 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 0.89922010 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88137910 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.87497545 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86815668 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86473190 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84521546 |
| 62 | * Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.84180138 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82835186 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79811969 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.79236721 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.78386302 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74808010 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74224323 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.74146357 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.73963381 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 0.73912354 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73424552 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73143660 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72947658 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.71847487 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.71011094 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70247175 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66474893 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64883424 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63738617 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62730941 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62693769 |
| 83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62468398 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62098838 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61626043 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59300403 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59225873 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59106925 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.59100065 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58432232 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57947797 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56327239 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56299050 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55521580 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55128450 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55087197 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55059478 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54977959 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54742391 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53962454 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53551479 |
| 102 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53223045 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53160786 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52813573 |
| 105 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52397937 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52323481 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50827241 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50389206 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48686762 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46946791 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46163302 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45611229 |
| 113 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42512073 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42394984 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.41984010 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41803520 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41717922 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39776257 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39419708 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38995315 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.38904582 |
| 122 | Measles_Homo sapiens_hsa05162 | 0.36316022 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36181065 |
| 124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35914601 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33126582 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32881943 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.30751358 |
| 128 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30187339 |
| 129 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.21542663 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.20858684 |
| 131 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.15187123 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12517253 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11154019 |

